Related Experiment Video
Updated: Jan 25, 2026

Place and Response Learning in the Open-field Tower Maze
Published on: October 28, 2015
Cellular cardiomyoplasty: what have we learned?
Race L Kao1, William Browder, Chuanfu Li
1Department of Surgery, James H Quillen College of Medicine, East Tennessee State University, Johnson City. kao@etsu.edu
Insights
Cellular cardiomyoplasty using stem cells shows promise for repairing heart damage after myocardial infarction. Meta-analyses reveal improved heart function and reduced adverse events, though further trials are needed.
Area of Science:
- Regenerative Medicine
- Cardiology
- Stem Cell Therapy
Background:
- Acute myocardial infarction (AMI) leads to significant heart damage, with limited restorative options beyond cardiac transplantation.
- Adult mammalian ventricular myocardium has poor natural regeneration capacity, creating a need for novel therapeutic approaches.
- Cellular cardiomyoplasty, first reported in 1989, utilizes stem cells to potentially repair damaged heart tissue.
Purpose of the Study:
- To critically review the progress and current status of cellular cardiomyoplasty for myocardial repair.
- To identify the limitations and future research directions for optimizing stem cell therapy in cardiology.
- To synthesize findings from experimental and clinical studies on the efficacy of stem cell-based cardiac repair.
Main Methods:
- Meta-analysis of stem cell-treated groups compared to control groups.
- Review of experimental and clinical studies on cellular cardiomyoplasty.
- Analysis of reported clinical findings using satellite or bone marrow stem cells.
Main Results:
- Stem cell therapy significantly improved left ventricular ejection fraction.
- Reduced infarct scar size and left ventricular end-systolic volume were observed in treated groups.
- Additional benefits included fewer myocardial infarctions, deaths, heart failure readmissions, and repeat revascularizations.
Conclusions:
- Cellular cardiomyoplasty offers a promising new avenue for myocardial repair, overcoming the limited regeneration of adult heart tissue.
- While meta-analyses show significant benefits, large-scale, placebo-controlled, double-blind randomized trials are essential to confirm long-term efficacy.
- Further research is needed to elucidate the precise mechanisms of benefit and optimize cell type, number, timing, and delivery methods for improved outcomes.
Abstract:
Restoring blood flow, improving perfusion, reducing clinical symptoms, and augmenting ventricular function are the goals after acute myocardial infarction. Other than cardiac transplantation, no standard clinical procedure is available to restore damaged myocardium. Since we first reported cellular cardiomyoplasty in 1989, successful outcomes have been confirmed by experimental and clinical studies, but definitive long-term efficacy requires large-scale placebo-controlled double-blind randomized trials. On meta-analysis, stem cell-treated groups had significantly improved left ventricular ejection fraction, reduced infarct scar size, and decreased left ventricular end-systolic volume. Fewer myocardial infarctions, deaths, readmissions for heart failure, and repeat revascularizations were additional benefits. Encouraging clinical findings have been reported using satellite or bone marrow stem cells, but understanding of the benefit mechanisms demands additional studies. Adult mammalian ventricular myocardium lacks adequate regeneration capability, and cellular cardiomyoplasty offers a new way to overcome this; the poor retention and engraftment rate and high apoptotic rate of the implanted stem cells limit outcomes. The ideal type and number of cells, optimal timing of cell therapy, and ideal cell delivery method depend on determining the beneficial mechanisms. Cellular cardiomyoplasty has progressed rapidly in the last decade. A critical review may help us to better plan the future direction.
Related Concept Videos
Learning Disabilities
Dyslexia
Dyslexia is a...
Avoidance Learning and Learned Helplessness
Avoidance learning occurs when an organism learns that a specific behavior can prevent an unpleasant outcome. For example, a student who receives a bad grade may start studying harder to avoid future poor grades. This behavior persists even when the negative outcome is no longer present. Avoidance learning is powerful because it maintains behavior in the absence of the...
Associative Learning
Classical conditioning, also known...
Purposive Learning
Observational Learning
Introduction to Learning
In contrast to learned behaviors, unlearned behaviors such as crying, sexual...

